Skip to content
ADRI
  • Home
  • About
    • Asbestos Diseases Research Institute
    • Asbestos Diseases Research Foundation
    • Annual Reports
    • News
    • Newsletters
  • Research
    • Senior Staff
    • Advisors
    • Current Research
    • Publications
    • Careers
    • International Collaboration
  • Support
    • ADRI Mesothelioma Support Service
    • Victim Support Groups
    • Support Us
  • Mesothelioma
    • Mesothelioma
    • Understanding Mesothelioma
    • Guidelines for diagnosis & treatment
    • International Collaboration
  • Asbestos Awareness
    • What is Asbestos?
    • Asbestos in Australia
    • Australian Government
    • NSW Government – SafeWork NSW
    • Organisation Links
    • International Collaboration
  • Students
    • Postgraduate Studies
  • Contact
Donate Now
ADRI
  • Home
  • About
    • Asbestos Diseases Research Institute
    • Asbestos Diseases Research Foundation
    • Annual Reports
    • News
    • Newsletters
  • Research
    • Senior Staff
    • Advisors
    • Current Research
    • Publications
    • Careers
    • International Collaboration
  • Support
    • ADRI Mesothelioma Support Service
    • Victim Support Groups
    • Support Us
  • Mesothelioma
    • Mesothelioma
    • Understanding Mesothelioma
    • Guidelines for diagnosis & treatment
    • International Collaboration
  • Asbestos Awareness
    • What is Asbestos?
    • Asbestos in Australia
    • Australian Government
    • NSW Government – SafeWork NSW
    • Organisation Links
    • International Collaboration
  • Students
    • Postgraduate Studies
  • Contact

ADRI publishes new research

December 19, 2014

The team at ADRI recently had their work on the use of a tumour microRNA signature to predict outcomes in malignant pleural mesothelioma patients accepted for publication in the journal Molecular Oncology. See the article here

← ADRI Scientists present at the 2014 iMig ConferenceADRI Scientist awarded PhD scholarship →

Search

Latest News

  • Congratulations and Thank You Sandie and PhysioWise
  • Teleconference Meeting with Mesothelioma Patients amid the COVID-19 Lockdown
  • ADRI and the Covid-19
  • The Post-Disaster Asbestos Hazard: 1995-2020
  • Asbestos & Bushfires

Donate Now

How To Donate

The rate of malignant mesothelioma is expected to continue to rise for at least the next 20 years. Your donation can help us fight this disease. Click here to learn more or click here to make a secure credit card donation.

ADRI Logo 300x86 white text no image
  • Home
  • Current Research
  • Publications
  • MPM Guidelines
  • Careers
  • Postgraduate Studies
  • Mesothelioma
  • Understanding MPM
  • What is Asbestos?
  • International Collaboration
  • Mesothelioma Support Coordinators
  • Victim Support Groups
  • Donate Now
  • Contact
  • Ph. (02) 9767 9800(02) 9767 9800
  • Fax. (02) 9767 9860
  • info@adri.org.au
  • Gate 3 Hospital Road
  • Concord Hospital
  • Concord NSW 2139
  • Australia
  • PO Box 3628
  • Rhodes NSW 2138
  • Australia
              

© 2021 Asbestos Diseases Research Institute | ABN 79 121 168 867 | Privacy | Sitemap | Website by SB Web Designs